Evidence map›Paper›PMID 38755008›Full record

ArticleJournal of microbiology and biotechnology2024

A Novel Inhibitor of Translation Initiation Factor eIF5B in

Ah-Ra Goh, Yi-Na Kim, Jae Hyeun Oh, Sang Ki Choi

Abstract read
In one paragraph

Article in Journal of microbiology and biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Ah-Ra GohDepartment of Biomedical Sciences, Sunchon National University, Sunchon 57922, Republic of Korea.
Yi-Na KimDepartment of Biomedical Sciences, Sunchon National University, Sunchon 57922, Republic of Korea.
Jae Hyeun OhDepartment of Biomedical Sciences, Sunchon National University, Sunchon 57922, Republic of Korea.
Sang Ki ChoiDepartment of Biomedical Sciences, Sunchon National University, Sunchon 57922, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The eukaryotic translation initiation factor eIF5B is a bacterial IF2 ortholog that plays an important role in ribosome joining and stabilization of the initiator tRNA on the AUG start codon during the initiation of translation. We identified the fluorophenyl oxazole derivative 2,2-dibromo-1-(2-(4-fluorophenyl)benzo[d]oxazol-5-yl)ethanone quinolinol as an inhibitor of fungal protein synthesis using an in vitro translation assay in a fungal system. Mutants resistant to this compound were isolated in

Indexed as

Antifungal AgentsEukaryotic Initiation FactorsSaccharomyces cerevisiaeAmino Acid SubstitutionDrug Resistance, FungalMutationProtein BiosynthesisProtein Synthesis InhibitorsSaccharomyces cerevisiae ProteinsAntifungal Agentseukaryotic initiation factor-5BEukaryotic Initiation FactorsProtein Synthesis InhibitorsSaccharomyces cerevisiae ProteinsantifungaleIF5BtargetTranslation inhibitortranslation initiation factor

Identifiers

PMID38755008
PMCPMC11239407

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.